Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Regulatory News (GSK)

Share Price Information for Glaxosmithkline (GSK)

Share Price is delayed by 15 minutes
Get Live Data
1,851.50    31.00 (1.70%)
Bid:
1,851.50
Ask:
1,852.00
Spread: 0.50 (0.027%)
Market Cap: £74.25b
GSK Live PriceLast checked at - London Stock Exchange

Intraday Glaxosmithkline Share Chart

Total Voting Rights

3 Mar 2025 15:00

RNS Number : 1444Z
GSK PLC
03 March 2025
 

GSK plc

 

Total Voting Rights and Capital

 

In conformity with the Financial Conduct Authority's Disclosure Guidance and Transparency Rule 5.6.1R, GSK plc (the 'Company') hereby notifies the market of the following:

 

The Company's issued share capital as at 28 February 2025 consisted of 4,315,177,430 shares of 31 ¼ pence each ('Ordinary Shares'), of which 173,023,905 Ordinary Shares were held in Treasury.

 

Therefore, the total number of voting rights in the Company is 4,142,153,525. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

 

Notifications may be sent to company.secretary@gsk.com.

 

 

V A Whyte

Company Secretary

 

3 March 2025

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVRBSGDXLXGDGUX
Date   Source Headline
11th Nov 20257:00 amRNSTransaction in Own Shares
10th Nov 20253:00 pmRNSGSK publishes provisional dividend dates
10th Nov 20257:00 amRNSTransaction in Own Shares
7th Nov 20257:00 amRNSTransaction in Own Shares
6th Nov 20257:00 amRNSTransaction in Own Shares
5th Nov 20257:00 amRNSTransaction in Own Shares
4th Nov 20257:00 amRNSTransaction in Own Shares
3rd Nov 20253:00 pmRNSTotal Voting Rights
3rd Nov 20257:00 amRNSTransaction in Own Shares
31st Oct 20257:00 amRNSTransaction in Own Shares
30th Oct 20253:30 pmRNSDirector/PDMR Shareholding
30th Oct 20257:00 amRNSTransaction in Own Shares
29th Oct 20257:05 amRNSTransaction in Own Shares
29th Oct 20257:00 amRNS3rd Quarter Results
28th Oct 20257:00 amRNSTransaction in Own Shares
28th Oct 20257:00 amRNSGSK ADC gets orphan drug designation in the EU
27th Oct 20257:00 amRNSTransaction in Own Shares
24th Oct 20257:00 amRNSBlenrep approved by US FDA in multiple myeloma
24th Oct 20257:00 amRNSTransaction in Own Shares
23rd Oct 20257:00 amRNSTransaction in Own Shares
22nd Oct 20257:05 amRNSPositive data for low carbon version Ventolin MDI
22nd Oct 20257:00 amRNSTransaction in Own Shares
22nd Oct 20257:00 amRNSLatozinemab data read out
21st Oct 20257:05 amRNSPositive CHMP Opinion for GSK on Shingrix PFS
21st Oct 20257:00 amRNSTransaction in Own Shares
21st Oct 20257:00 amRNSGSK share positive Ph3 data on tebipenem HBr
20th Oct 20257:00 amRNSTransaction in Own Shares
17th Oct 20257:00 amRNSTransaction in Own Shares
16th Oct 20253:30 pmRNSDirector/PDMR Shareholding
16th Oct 20257:00 amRNSTransaction in Own Shares
15th Oct 20253:30 pmRNSDirector/PDMR Shareholding
15th Oct 20257:00 amRNSTransaction in Own Shares
14th Oct 20257:00 amRNSGSK receives expanded Shingrix approval in China
14th Oct 20257:00 amRNSTransaction in Own Shares
13th Oct 20253:30 pmRNSDirector/PDMR Shareholding
13th Oct 20257:00 amRNSTransaction in Own Shares
10th Oct 20253:30 pmRNSDirector/PDMR Shareholding
10th Oct 20257:00 amRNSTransaction in Own Shares
9th Oct 20257:00 amRNSTransaction in Own Shares
8th Oct 20257:00 amRNSTransaction in Own Shares
7th Oct 20257:00 amRNSTransaction in Own Shares
6th Oct 20257:00 amRNSTransaction in Own Shares
3rd Oct 20257:00 amRNSTransaction in Own Shares
2nd Oct 20257:00 amRNSTransaction in Own Shares
1st Oct 20253:00 pmRNSTotal Voting Rights
1st Oct 20257:00 amRNSTransaction in Own Shares
30th Sep 20257:00 amRNSGSK - third tranche of share buyback programme
29th Sep 20257:00 amRNSGSK appoints CEO designate
22nd Sep 20253:30 pmRNSDirector/PDMR Shareholding
19th Sep 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.